Inventor · disambiguated record
Jeffrey A. Bacha
Also filed as: BACHA JEFFREY · BACHA JEFFREY A
8 granted patents·12 pending applications·11 citations·filing 2013–2023
81Inventor score
Files withDEL MAR PHARMACEUTICALS BC LTD9DELMAR PHARMACEUTICALS INC8BACHA JEFFREY1BACHA JEFFREY A1DEL MAR PHARMACEUTICALS1
Top patents by PatentIndex Score
20 records- 0181US9687466B2Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiformeDELMAR PHARMACEUTICALS INC·Filed 2014·Granted Jun 27, 2017·5 cites·42 claims
- 0279US11717505B2Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomasDEL MAR PHARMACEUTICALS BC LTD·Filed 2018·Granted Aug 8, 2023·1 cites·11 claims
- 0376US2022193024A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2022·Application pending·0 cites
- 0475US2022142966A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2022·Application pending·0 cites
- 0572US11234955B2Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2019·Granted Feb 1, 2022·0 cites·7 claims
- 0672US9814693B2Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignanciesDELMAR PHARMACEUTICALS INC·Filed 2013·Granted Nov 14, 2017·2 cites·5 claims
- 0771US11446274B2Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignanciesDELMAR PHARMACEUTICALS INC·Filed 2016·Granted Sep 20, 2022·1 cites·4 claims
- 0871US10201521B2Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2013·Granted Feb 12, 2019·1 cites·6 claims
- 0969US2023338325A1Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomasDEL MAR PHARMACEUTICALS BC LTD·Filed 2023·Application pending·0 cites
- 1062US11026914B2Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumorDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Jun 8, 2021·1 cites·8 claims
- 1162US2021251944A1Methods for treating a cancer resistant to at least one tyrosine kinase inhibitorDEL MAR PHARMACEUTICALS BC LTD·Filed 2021·Application pending·0 cites
- 1258US2017266150A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastomaDELMAR PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1355US11541027B2Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastasesDELMAR PHARMACEUTICALS INC·Filed 2015·Granted Jan 3, 2023·0 cites·33 claims
- 1453US2019183843A9Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignanciesDELMAR PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1548US2015182490A1Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereofDEL MAR PHARMACEUTICALS·Filed 2013·Application pending·0 cites
- 1643US2020061054A1Use of dianhydrogalactitol or analogs and derivatives in combination with a p53 modulator or a parp inhibitorDEL MAR PHARMACEUTICALS BC LTD·Filed 2018·Application pending·0 cites
- 1741US2018140571A1Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastasesBACHA JEFFREY·Filed 2016·Application pending·0 cites
- 1839US2020062839A1Use of dianhydrogalactitol or analogs and derivatives in combination with vegf inhibitors to treat cancerDEL MAR PHARMACEUTICALS BC LTD·Filed 2018·Application pending·0 cites
- 1936US2019091195A1Use of dianhydrogalactitol and derivatives thereof in the treatment of glioblastoma, lung cancer, and ovarian cancerBACHA JEFFREY A·Filed 2016·Application pending·0 cites
- 2029US2019015379A1Use of dianhydrogalactitol and analogs and derivatives thereof, together with radiation, to treat non-small-cell carcinoma of the lung and glioblastoma multiforme and suppress proliferation of cancer stem cellsDELMAR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey A. Bacha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →